Hi, what are you looking for?
Natera (NASDAQ:NTRA) acquired full enrolment for the RenaCARE (Renasight Clinical Application, Review and Evaluation) study, which is a prospective, multi-center clinical trial to determine...
ALS affects up to 30,000 people in the United States with 5,000 new cases every year, according to John Hopkins Medicine.
The agency says it supports research into the substances and it's necessary for the FDA to approve new quotas
Through its university partnership, the firm wants to attract big pharma backers by making 100,000s of novel psychedelic derivatives for new precision medicine
As part of National Pain Awareness Week, Canopy's chief medical officer discusses how Canadians are navigating chronic pain with weed
Mugglehead talks to University of British Columbia's M-J Milloy who is studying how cannabis might help with opioid addiction while big pharma is being...